Great Ormond Street Childrens Hospital National Health Service Trust

London, United Kingdom

Great Ormond Street Childrens Hospital National Health Service Trust

London, United Kingdom

Time filter

Source Type

Moratto D.,University of Brescia | Giliani S.,University of Brescia | Bonfim C.,Federal University of Paraná | Mazzolari E.,Spedali Civili | And 30 more authors.
Blood | Year: 2011

In this retrospective collaborative study, we have analyzed long-term outcome and donor cell engraftment in 194 patients with Wiskott-Aldrich syndrome (WAS) who have been treated by hematopoietic cell transplantation (HCT) in the period 1980-2009. Overall survival was 84.0% and was even higher (89.1% 5-year survival) for those who received HCT since the year 2000, reflecting recent improvement of outcome after transplantation from mismatched family donors and for patients who received HCT from an unrelated donor at older than 5 years. Patients who went to transplantation in better clinical conditions had a lower rate of post-HCT complications. Retrospective analysis of lineage-specific donor cell engraftment showed that stable full donor chimerism was attained by 72.3% of the patients who survived for at least 1 year after HCT. Mixed chimerism was associated with an increased risk of incomplete reconstitution of lymphocyte count and post-HCT autoimmunity, and myeloid donor cell chimerism < 50% was associated with persistent thrombocytopenia. These observations indicate continuous improvement of outcome after HCT for WAS and may have important implications for the development of novel protocols aiming to obtain full correction of the disease and reduce post-HCT complications. © 2011 by The American Society of Hematology.

Loading Great Ormond Street Childrens Hospital National Health Service Trust collaborators
Loading Great Ormond Street Childrens Hospital National Health Service Trust collaborators